Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exodus Movement (EXOD) Cash & Current Investments (2023 - 2025)

Exodus Movement has reported Cash & Current Investments over the past 3 years, most recently at $4.9 million for Q4 2025.

  • Quarterly results put Cash & Current Investments at $4.9 million for Q4 2025, down 86.97% from a year ago — trailing twelve months through Dec 2025 was $4.9 million (down 86.97% YoY), and the annual figure for FY2025 was $4.9 million, down 86.97%.
  • Cash & Current Investments for Q4 2025 was $4.9 million at Exodus Movement, down from $50.5 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for EXOD hit a ceiling of $59.8 million in Q1 2025 and a floor of $4.9 million in Q4 2025.
  • Median Cash & Current Investments over the past 3 years was $27.2 million (2024), compared with a mean of $30.5 million.
  • Biggest five-year swings in Cash & Current Investments: surged 233.01% in 2024 and later plummeted 86.97% in 2025.
  • Exodus Movement's Cash & Current Investments stood at $11.4 million in 2023, then surged by 233.01% to $37.9 million in 2024, then plummeted by 86.97% to $4.9 million in 2025.
  • The last three reported values for Cash & Current Investments were $4.9 million (Q4 2025), $50.5 million (Q3 2025), and $52.9 million (Q2 2025) per Business Quant data.